• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁丙诺啡-纳洛酮治疗提供者的报销和实践政策。

Reimbursement and practice policies among providers of buprenorphine-naloxone treatment.

机构信息

Department of Family Medicine, School of Medicine and Biomedical Sciences, and Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 14203, USA.

出版信息

Subst Abus. 2013;34(2):105-7. doi: 10.1080/08897077.2012.677753.

DOI:10.1080/08897077.2012.677753
PMID:23577902
Abstract

UNLABELLED

ABSTRACT Background: Physician acceptance of cash payment and low adherence to practice guidelines may contribute to buprenorphine-naloxone diversion. The purpose of this study was to investigate the clinical practice policies of physicians who provide office-based treatment for opioid dependence with buprenorphine-naloxone.

METHODS

Data were obtained from 31 of 71 practices surveyed (response rate 43.7%) that provided answers to at least some of the survey questions.

RESULTS

Of these practices, 28 (90.3%) accepted cash as payment and 6 (19.4%) accepted only cash for treatment services. Analysis of open-ended responses to questions about office policies revealed wide variation among practices and overall suboptimal adherence to recommended treatment guidelines.

CONCLUSIONS

These results underscore the need for continuing education for physicians who prescribe buprenorphine-naloxone.

摘要

目的

背景:医师接受现金支付以及对实践指南的低遵从度可能导致丁丙诺啡-纳洛酮的滥用。本研究旨在调查提供丁丙诺啡-纳洛酮门诊治疗的医师的临床实践政策。

方法

数据来自 71 个调查实践中的 31 个(应答率 43.7%),这些实践提供了至少部分调查问题的答案。

结果

在这些实践中,28 个(90.3%)接受现金支付,6 个(19.4%)仅接受现金支付治疗服务。对有关办公室政策的开放式问题的分析显示,实践之间存在很大差异,总体上对推荐的治疗指南的遵从度不佳。

结论

这些结果强调了需要对开具丁丙诺啡-纳洛酮的医师进行继续教育。

相似文献

1
Reimbursement and practice policies among providers of buprenorphine-naloxone treatment.丁丙诺啡-纳洛酮治疗提供者的报销和实践政策。
Subst Abus. 2013;34(2):105-7. doi: 10.1080/08897077.2012.677753.
2
Geographic and specialty distribution of US physicians trained to treat opioid use disorder.接受过治疗阿片类药物使用障碍培训的美国医生的地理分布和专业分布。
Ann Fam Med. 2015 Jan-Feb;13(1):23-6. doi: 10.1370/afm.1735.
3
Diversion and abuse of buprenorphine: findings from national surveys of treatment patients and physicians.丁丙诺啡的转移和滥用:来自治疗患者和医生全国调查的结果。
Drug Alcohol Depend. 2012 Jan 1;120(1-3):190-5. doi: 10.1016/j.drugalcdep.2011.07.019. Epub 2011 Aug 21.
4
Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.丁丙诺啡/纳洛酮与美沙酮治疗阿片类药物依赖:一项纵向调查。
Eur Rev Med Pharmacol Sci. 2011 Aug;15(8):871-4.
5
Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients.医生对阿片类药物替代治疗患者药物转移和注射的看法。
Drug Alcohol Rev. 2011 Nov;30(6):613-20. doi: 10.1111/j.1465-3362.2010.00274.x. Epub 2011 Jan 5.
6
Analysis of buprenorphine/naloxone dosing impact on treatment duration, resource use and costs in the treatment of opioid-dependent adults: a retrospective study of US public and private health care claims.丁丙诺啡/纳洛酮剂量对阿片类药物依赖成人治疗持续时间、资源利用和成本的影响分析:一项对美国公共和私人医疗保健索赔的回顾性研究
Postgrad Med. 2014 Sep;126(5):113-20. doi: 10.3810/pgm.2014.09.2805.
7
Physician-pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients.针对丁丙诺啡维持治疗的阿片类药物依赖患者的医生-药剂师协作护理模式。
J Am Pharm Assoc (2003). 2015 Mar-Apr;55(2):187-92. doi: 10.1331/JAPhA.2015.14177.
8
The implementation of buprenorphine/naloxone in college health practice.丁丙诺啡/纳洛酮在大学健康实践中的应用
J Am Coll Health. 2008 Jan-Feb;56(4):391-3. doi: 10.3200/JACH.56.44.391-394.
9
Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.使用丁丙诺啡和纳洛酮舌下片剂配方在门诊治疗阿片类药物成瘾。
N Engl J Med. 2003 Sep 4;349(10):949-58. doi: 10.1056/NEJMoa022164.
10
Treating opioid addiction with buprenorphine-naloxone in community-based primary care settings.在社区基层医疗环境中使用丁丙诺啡-纳洛酮治疗阿片类药物成瘾。
Ann Fam Med. 2007 Mar-Apr;5(2):146-50. doi: 10.1370/afm.665.

引用本文的文献

1
Prospective Study on Factors Associated with Referral of Patients with Opioid Maintenance Therapy from Specialized Addictive Disorders Centers to Primary Care.关于阿片类药物维持治疗患者从专门的成瘾性疾病中心转诊至初级保健相关因素的前瞻性研究。
Int J Environ Res Public Health. 2021 May 27;18(11):5749. doi: 10.3390/ijerph18115749.
2
Proliferation of Cash-Only Buprenorphine Treatment Clinics: A Threat to the Nation's Response to the Opioid Crisis.仅提供丁丙诺啡治疗的诊所激增:对国家应对阿片类药物危机的威胁。
Am J Public Health. 2019 Mar;109(3):393-394. doi: 10.2105/AJPH.2018.304899.
3
Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees.
多州医疗补助参保者样本中阿片类药物使用障碍患者丁丙诺啡治疗中断的风险因素。
J Subst Abuse Treat. 2018 Dec;95:9-17. doi: 10.1016/j.jsat.2018.09.001. Epub 2018 Sep 7.
4
Service providers' adherence to methadone maintenance treatment protocol in China.中国美沙酮维持治疗服务提供者的遵医行为。
Int J Drug Policy. 2018 Jun;56:1-5. doi: 10.1016/j.drugpo.2018.02.018. Epub 2018 Mar 9.
5
Access to and Payment for Office-Based Buprenorphine Treatment in Ohio.俄亥俄州基于办公室的丁丙诺啡治疗的获取与支付
Subst Abuse. 2017 Jun 13;11:1178221817699247. doi: 10.1177/1178221817699247. eCollection 2017.
6
Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population.多州人群中丁丙诺啡-纳洛酮治疗阿片类物质使用障碍的模式
Med Care. 2017 Jul;55(7):669-676. doi: 10.1097/MLR.0000000000000727.
7
French Experience with Buprenorphine : Do Physicians Follow the Guidelines?法国丁丙诺啡的使用经验:医生是否遵循指南?
PLoS One. 2015 Oct 19;10(10):e0137708. doi: 10.1371/journal.pone.0137708. eCollection 2015.
8
Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties.用于治疗阿片类药物使用障碍的丁丙诺啡在哪里配发?私人诊所、阿片类药物治疗项目以及城乡县的药物滥用治疗设施所起的作用。
Milbank Q. 2015 Sep;93(3):561-83. doi: 10.1111/1468-0009.12137.